JUPITER, FL — In recognition of his high-impact work advancing the field of RNA-targeting medicines, the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, has awarded Scripps Research Chemistry Professor Matthew Disney, PhD , a prestigious Research Program Award, to aid Disney’s development of treatments for incurable diseases such as Alzheimer’s, Parkinson’s, ALS and frontotemporal dementia.
↧